← TrialMatch
HomeTrials

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

This study was an ambispective observational cohort study that included sepsis patients hospitalized in the Intensive care unit (ICU) of the Nankai Hospital. All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors

Condition(s)Sepsis
StatusRecruiting
Study typeObservational
SummaryThis study was an ambispective observational cohort study that included sepsis patients hospitalized in the Intensive care unit (ICU) of the Nankai Hospital. All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.
Who can participateInclusion Criteria: 1. Males or females over the age of 18; 2. Sepsis was diagnosed within 48h which meets SPESIS 3 criteria; 3. Capable of understanding the purpose and risk of the study; 4. Patients or proxy must give written informed consent before any assessment is performed. Exclusion Criteria: 1. Pregnancy, lactation or perinatal period; 2. Breast carcinoma; 3. HIV seropositive or Syphilis seropositive; 4. Any clinical-relevant condition that might affect study participation and/or study results; 5. Participation in any other intervention trial; 6. Unwillingness or inability to following the study protocol in the investigators opinion.
Ages18 Years to 100 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorTianjin Nankai Hospital
LocationsTianjin, Tianjin Municipality, China
Start date2023-09-15
NCT IDNCT06045780
Official listinghttps://clinicaltrials.gov/study/NCT06045780

🔍 Search all trials →